Educational attainment inequalities in depressive symptoms in more than 100,000 individuals in Europe.


Journal

European psychiatry : the journal of the Association of European Psychiatrists
ISSN: 1778-3585
Titre abrégé: Eur Psychiatry
Pays: England
ID NLM: 9111820

Informations de publication

Date de publication:
16 11 2020
Historique:
pubmed: 17 11 2020
medline: 1 5 2021
entrez: 16 11 2020
Statut: epublish

Résumé

Increasing educational attainment (EA) could decrease the occurrence of depression. We investigated the relationship between EA and depressive symptoms in older individuals across four European regions. We studied 108,315 Europeans (54% women, median age 63 years old) from the Survey on Health, Ageing and Retirement in Europe assessing EA (seven educational levels based on International Standard Classification of Education [ISCED] classification) and depressive symptoms (≥4 points on EURO-D scale). Logistic regression estimated the association between EA and depressive symptoms, adjusting for sociodemographic and health-related factors, testing for sex/age/region and education interactions. Higher EA was associated with lower odds of depressive symptoms, independent of sociodemographic and health-related factors. A threshold of the lowest odds of depressive symptoms was detected at the first stage of tertiary education (OR 0.60; 95% confidence interval [CI] 0.55-0.65; p < 0.001; relative to no education). Central and Eastern Europe showed the strongest association (OR for high vs. low education 0.37; 95% CI 0.33-0.40; p < 0.001) and Scandinavia the weakest (OR for high vs. low education 0.69; 95% CI 0.60-0.80; p < 0.001). The association was strongest among younger individuals. There was a sex and education interaction only within Central and Eastern Europe. Level of EA is reflected in later-life depressive symptoms, suggesting that supporting individuals in achieving EA, and considering those with lower EA at increased risk for depression, could lead to decreased burden of depression across the life course. Further educational support in Central and Eastern Europe may decrease the higher burden of depressive symptoms in women.

Sections du résumé

BACKGROUND
Increasing educational attainment (EA) could decrease the occurrence of depression. We investigated the relationship between EA and depressive symptoms in older individuals across four European regions.
METHODS
We studied 108,315 Europeans (54% women, median age 63 years old) from the Survey on Health, Ageing and Retirement in Europe assessing EA (seven educational levels based on International Standard Classification of Education [ISCED] classification) and depressive symptoms (≥4 points on EURO-D scale). Logistic regression estimated the association between EA and depressive symptoms, adjusting for sociodemographic and health-related factors, testing for sex/age/region and education interactions.
RESULTS
Higher EA was associated with lower odds of depressive symptoms, independent of sociodemographic and health-related factors. A threshold of the lowest odds of depressive symptoms was detected at the first stage of tertiary education (OR 0.60; 95% confidence interval [CI] 0.55-0.65; p < 0.001; relative to no education). Central and Eastern Europe showed the strongest association (OR for high vs. low education 0.37; 95% CI 0.33-0.40; p < 0.001) and Scandinavia the weakest (OR for high vs. low education 0.69; 95% CI 0.60-0.80; p < 0.001). The association was strongest among younger individuals. There was a sex and education interaction only within Central and Eastern Europe.
CONCLUSIONS
Level of EA is reflected in later-life depressive symptoms, suggesting that supporting individuals in achieving EA, and considering those with lower EA at increased risk for depression, could lead to decreased burden of depression across the life course. Further educational support in Central and Eastern Europe may decrease the higher burden of depressive symptoms in women.

Identifiants

pubmed: 33190666
doi: 10.1192/j.eurpsy.2020.100
pii: S0924933820001005
pmc: PMC7737177
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e97

Subventions

Organisme : NIA NIH HHS
ID : HHSN271201300071C
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG025169
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG005842
Pays : United States

Références

Int J Epidemiol. 2005 Apr;34(2):295-305
pubmed: 15563586
J Health Soc Behav. 2008 Mar;49(1):72-91
pubmed: 18418986
Eur Psychiatry. 2019 Jun;59:37-43
pubmed: 31009916
Int J Methods Psychiatr Res. 2018 Sep;27(3):e1728
pubmed: 29926999
J Adolesc Health. 2009 Aug;45(2):179-86
pubmed: 19628145
Soc Sci Med. 2015 Dec;146:75-84
pubmed: 26513116
Sociol Health Illn. 2013 Nov;35(8):1242-59
pubmed: 23909439
Br J Psychiatry. 1999 Apr;174:330-8
pubmed: 10533552
J Affect Disord. 2020 Jan 15;261:139-144
pubmed: 31627114
Soc Sci Med. 2008 Mar;66(6):1334-45
pubmed: 18234406
BMJ. 2010 Feb 23;340:c654
pubmed: 20179132
Eur J Public Health. 2020 Oct 1;30(5):948-952
pubmed: 32335678
Am Sociol Rev. 2012 Aug 1;77(4):548-572
pubmed: 25346542
Res Aging. 2011 Mar;33(2):145-171
pubmed: 21897495
Neurology. 2018 Oct 23;91(17):e1602-e1610
pubmed: 30258021
J Alzheimers Dis. 2019;72(3):693-701
pubmed: 31609688
PLoS One. 2008;3(11):e3639
pubmed: 18982064
Am J Geriatr Psychiatry. 2006 Jan;14(1):27-35
pubmed: 16407579
Soc Psychiatry Psychiatr Epidemiol. 2020 Aug 12;:
pubmed: 32789560
Neurology. 2007 Oct 2;69(14):1442-50
pubmed: 17909157
Soc Sci Med. 2012 Mar;74(5):734-43
pubmed: 22300713
J Affect Disord. 2020 Jul 1;272:17-23
pubmed: 32379611
Eur Psychiatry. 2019 Apr;57:19-25
pubmed: 30658276
Soc Sci Med. 2006 Sep;63(5):1400-13
pubmed: 16644077
Soc Ment Health. 2015 Jul;5(2):145-161
pubmed: 27840772
Soc Sci Med. 2015 Feb;127:63-73
pubmed: 25113567
BMJ Open. 2019 Nov 14;9(11):e031595
pubmed: 31727656
Health Aff (Millwood). 2008 Mar-Apr;27(2):350-60
pubmed: 18332489
Int J Epidemiol. 2013 Aug;42(4):992-1001
pubmed: 23778574
Int J Epidemiol. 2009 Oct;38(5):1310-22
pubmed: 19528192
Eur Psychiatry. 2019 Aug;60:1-6
pubmed: 31096115
Soc Sci Med. 2008 Apr;66(7):1588-602
pubmed: 18222580

Auteurs

Adam Chlapecka (A)

Third Faculty of Medicine, Charles University Prague, Prague, Czech Republic.

Anna Kagstrom (A)

Third Faculty of Medicine, Charles University Prague, Prague, Czech Republic.
National Institute of Mental Health, Klecany, Czech Republic.

Pavla Cermakova (P)

Third Faculty of Medicine, Charles University Prague, Prague, Czech Republic.
National Institute of Mental Health, Klecany, Czech Republic.
Second Faculty of Medicine, Charles University Prague, Prague, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH